TY - JOUR
T1 - Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure
AU - Lu, Kuo Cheng
AU - Shieh, S. D.
AU - Lin, S. H.
AU - Chyr, S. H.
AU - Lin, Y. F.
AU - Diang, L. K.
AU - Li, B. L.
AU - Sheu, W. H.H.
AU - Ding, Y. A.
PY - 1994/6
Y1 - 1994/6
N2 - Disturbance in the vitamin D/parathyroid hormone (PTH) axis may be important in the pathogenesis of glucose intolerance and insulin resistance in uraemia. To investigate possible relationships between hyperparathyroidism, intracellular free calcium ([Ca2+]1), and glucose tolerance in chronic renal failure, we measured serum intact PTH (l-PTH) by two-site immunometric assay, platelet [Ca2+]1 using the fluorescent indicator fura-2, and plasma glucose and insulin after 14 h overnight fast and at 30, 60 and 120 min following a 75 g oral glucose load, in 18 chronic haemodialysis patients with elevated serum l-PTH. Calcitriol (1 μg) was administered parenterally at the end of each dialysis session for four weeks. This significantly decreased serum l-PTH (p<0.001) and platelet [Ca2+], (p<0.01). Uraemic patients initially showed marked glucose intolerance, with increased area below the glucose curve compared to healthy controls, but after 4 weeks of calcitriol treatment, this effect was significantly decreased, and there was a significant rise in the area under the insulin curve after glucose load. The insulinogenic index also increased significantly after calcitriol treatment.
AB - Disturbance in the vitamin D/parathyroid hormone (PTH) axis may be important in the pathogenesis of glucose intolerance and insulin resistance in uraemia. To investigate possible relationships between hyperparathyroidism, intracellular free calcium ([Ca2+]1), and glucose tolerance in chronic renal failure, we measured serum intact PTH (l-PTH) by two-site immunometric assay, platelet [Ca2+]1 using the fluorescent indicator fura-2, and plasma glucose and insulin after 14 h overnight fast and at 30, 60 and 120 min following a 75 g oral glucose load, in 18 chronic haemodialysis patients with elevated serum l-PTH. Calcitriol (1 μg) was administered parenterally at the end of each dialysis session for four weeks. This significantly decreased serum l-PTH (p<0.001) and platelet [Ca2+], (p<0.01). Uraemic patients initially showed marked glucose intolerance, with increased area below the glucose curve compared to healthy controls, but after 4 weeks of calcitriol treatment, this effect was significantly decreased, and there was a significant rise in the area under the insulin curve after glucose load. The insulinogenic index also increased significantly after calcitriol treatment.
UR - http://www.scopus.com/inward/record.url?scp=0028243517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028243517&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.qjmed.a068941
DO - 10.1093/oxfordjournals.qjmed.a068941
M3 - Article
C2 - 8041868
AN - SCOPUS:0028243517
SN - 1460-2725
VL - 87
SP - 359
EP - 365
JO - QJM
JF - QJM
IS - 6
ER -